The 2009-2014 World Outlook for Medicated Skin Care

Countries covered: Global This econometric study covers the world outlook for medicated skin care across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for medicated skin care. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Additional Information

This econometric study covers the world outlook for medicated skin care across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

More Global Dermatology Reports

Alopecia Global Clinical Trials Review, H1, 2012 by GlobalData
Alopecia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Alopecia Global Clinical Trials Review, H1, 2012 provides data on the Alopecia clinical trial scenario. ...

Botulinum Toxin by Global Industry Analysts
This report analyzes the worldwide markets for Botulinum Toxin in US$ Million by the following Product Segments: Cosmetic Applications, and Therapeutic Applications. The report ...

World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) by Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological ...

Dermatological Drugs: World Market Prospects 2012-2022 by Visiongain
Where are dermatological treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses drugs to treat ...

Dermatological Drugs: World Market Prospects 2012-2022 by Visiongain
Where are dermatological treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses drugs to treat ...

See all reports like this >>